Napolitano, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 220
AS - Asia 57
AF - Africa 2
Totale 527
Nazione #
US - Stati Uniti d'America 247
SE - Svezia 67
IT - Italia 65
IE - Irlanda 23
CN - Cina 21
SG - Singapore 21
FR - Francia 18
DE - Germania 11
KR - Corea 10
RU - Federazione Russa 9
SI - Slovenia 6
FI - Finlandia 4
GB - Regno Unito 4
PT - Portogallo 4
IN - India 2
UA - Ucraina 2
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MK - Macedonia 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
Totale 527
Città #
Chandler 70
Ashburn 32
New York 27
Dublin 21
Rome 19
Singapore 14
Marseille 12
Boardman 11
Milan 10
Seoul 10
Beijing 8
Los Angeles 8
Moscow 7
Princeton 7
Boston 5
Bremen 4
Atlanta 3
Chelsea 3
Helsinki 3
Lisbon 3
San Diego 3
Washington 3
Ancona 2
Cagliari 2
Fairfield 2
Florence 2
Genzano di Roma 2
Houston 2
Munich 2
Oristano 2
Paris 2
Pune 2
Saint-Fons 2
San Mateo 2
Seattle 2
Abidjan 1
Arzachena 1
Augusta 1
Brno 1
Busto Arsizio 1
Ceriano Laghetto 1
Frankfurt am Main 1
Gdansk 1
Hackney 1
Hirakata 1
Iesi 1
Lagos 1
Lappeenranta 1
Leawood 1
Massa 1
Montreal 1
Monza 1
Naples 1
Ravenna 1
Sacramento 1
Santa Clara 1
Tallinn 1
Trieste 1
Wilmington 1
Zagreb 1
Totale 334
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 59
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 57
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 52
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 48
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 46
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 45
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 42
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 32
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 32
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 25
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 20
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey 19
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 17
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 10
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 10
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 10
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 8
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 5
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 5
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 4
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 3
Totale 549
Categoria #
all - tutte 3.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 1 2
2021/202258 1 0 0 2 1 0 0 3 0 18 16 17
2022/2023222 36 28 10 32 18 14 22 7 18 6 15 16
2023/2024251 6 40 16 19 11 35 21 7 17 21 24 34
2024/202515 8 7 0 0 0 0 0 0 0 0 0 0
Totale 549